GE Aerospace Stock Price, News & Analysis

The U.S. Air Force and GE initiated Phase 2 testing of the XA100 adaptive cycle engine on March 25, 2023, at the Arnold Engineering Development Complex. This engine is significant for the F-35’s future, having completed Phase 1 in November 2021. The XA100 includes innovations that enhance thrust by over 10% and fuel efficiency by 25%, while also being compatible with Sustainable Aviation Fuel. GE Edison Works oversees the development of this ground-breaking engine, which aims to reduce operational costs and ensure enhanced combat capabilities for the F-35.

GE Renewable Energy has unveiled the world's first 420 kV, 63 kA g³ gas-insulated substation (GIS) circuit-breaker prototype. This innovation marks a significant advancement in the power industry, offering a viable alternative to SF₆ gas. The g³ technology reduces greenhouse gas emissions by over 99%, contributing to cleaner electrical grids. The prototype, showcased to European transmission utilities, is expected for commercial release in 2023. This move aligns with GE's commitment to accelerating grid decarbonization through innovative solutions.

GE Healthcare has initiated a Phase III clinical trial for a new PET radiopharmaceutical aimed at aiding the evaluation of adult patients with suspected Parkinsonian syndromes. This trial follows the success of DaTscan, a leading SPECT agent, to enhance diagnostic imaging options. The study, taking place in France, compares PET technology's higher resolution against SPECT for better visualization of dopamine transporters. Additionally, a SPECT agent study will begin in the U.S. This expansion supports GE's commitment to improving patient care and aligns with the growing need for Parkinson’s disease diagnostics.

GE Renewable Energy’s Grid Solutions and BOND Civil & Utility Construction have secured an EPC contract from Empire Offshore Wind for the Empire Wind 1 project. This venture will deliver a digital onshore substation and integrate an 816-MW wind power project into the New York Power Grid. Upon completion, it will provide energy to over 500,000 homes in New York and contribute to the state's renewable energy goals, including a 70% generation target by 2030 and a zero-emission electricity sector by 2040.

GE Healthcare has partnered with AliveCor to integrate data from the KardiaMobile 6L personal ECG device into its MUSE cardiac management system. This collaboration enables physicians to access patient ECGs remotely, enhancing diagnostic capabilities and continuity of care. MUSE is already utilized by 87% of the top cardiac hospitals in the U.S. The integration aims to improve patient outcomes by reducing hospitalizations linked to cardiac conditions like atrial fibrillation. The KardiaMobile 6L provides medical-grade ECGs that help physicians monitor heart health conveniently.

GE Healthcare announced its plans to launch the Edison Digital Health Platform, a vendor-agnostic digital health solution designed to improve healthcare delivery efficiency and reduce IT burdens. At HIMSS 2022, the company revealed that the platform aims to aggregate data from various sources, enabling better patient care management through enhanced analytics and AI tools. Collaboration with ecosystem participants is underway to evaluate the platform's functionality, which promises to facilitate seamless app integration and improve clinicians' workflow.

Singapore Airlines (SIA) has placed an order for an additional 22 GE9X engines valued at $2.8 billion to power its Boeing 777-9 fleet. This order accompanies a 12-year GE TrueChoice™ services contract. With a total of 31 Boeing 777-9 aircraft on order, SIA is set to be the first airline in the Asia Pacific to operate this model. The GE9X engine boasts the highest pressure ratio of any commercial aircraft engine and is designed to operate efficiently with reduced emissions.